Pharmaceutical Lactose Market

2021 Analysis and Review: Pharmaceutical Lactose Market by Product Type – B-lactose, ?-Lactose Monohydrate, Amorphous Lactose, and Spray Dried Lactose for 2021 - 2031

About the Pharmaceutical Lactose Report

Increased access to medication through generic drug production, development of new treatments for chronic diseases, increasing research and development spending, rising competition, and advent of new technologies are driving the pharmaceutical lactose market.

The ability to perform various functions such as modifying drug release, taste masking accelerates, and improving active pharmaceutical ingredient stability are the major factors fuelling the for demand of pharmaceutical lactose. In addition to this, increasing adoption of excipients to enhance drug solubility and improve bioavailability has amped up the demand for pharmaceutical lactose.

In its new study, consulting firm Future Market Insights (FMI) offers insights about key factors driving demand for pharmaceutical lactose market. The report tracks the global sales of pharmaceutical lactose market in 20+ high-growth markets. This report gives details of the prospective growing markets in the gummy vitamins market and what are the driving factors of the pharmaceutical lactose market.

How the Historical and Future Outlook of Pharmaceutical Lactose Market Compare?

Rising preference toward preventive healthcare globally is anticipated to increase the demand for pharmaceutical lactose over the forecast period. Rising investments by local and foreign players in the pharmaceutical manufacturing sector, specifically in developing economies such as Brazil and China is anticipated to have a positive influence on pharmaceutical lactose industry growth.

In the past few years the awareness regarding functions and health benefits associated with pharmaceutical lactose has increased across the globe, leading to the influx of new players. Key producers are focusing on launching innovative products as well as focusing on partnerships to increase the production capacity.

According to FMI’s analysis, pharmaceutical lactose market have grown at 3.5% CAGR between 2016 and 2020.

Inhalation lactose is an excipient of high functionality that is helpful for the consistent performance of dry powder inhalation and thus ultimately to the patient’s wellbeing. Key players, end users, suppliers and regulators are working deeply to understand the inhalation lactose benefits and to adopt a various manufacturing strategy based on statistical models and to provide precise regulatory framework for advancement in forecast period. The significance of inhalation lactose in DPI performance has attracted a great deal of regulatory attention and the inhalation lactose remains an attraction in the global pharmaceutical lactose market.

The aim for improving palatability in oral drugs have driven the growth of various formulations with improved acceptability and performance. In recent years, mouth dissolving tablets have received important demand, and the field has become a rapidly growing area in the pharmaceutical industry. By numerous conventional methods, such as wet granulation, molding, direct compression, spray drying, sublimation and freeze drying etc. mouth dissolving tablets can be prepared

Will Use Of 3D Models Enhance Precision In Pharmaceutical Lactose?

In the pharmaceutical industry it is possible to design and manufacture novel complex drug products by using advent of 3D printing technology. 3D printing allows the creation of reliable dosage forms for clinical use and offers the capability to tailor doses for specific users.

To embrace new opportunities, pharmaceutical lactose manufacturers are adopting 3D technology for developing lactose blends with sufficient flow, wetting and binding. Benefits such as early phase drug development, high dose flexibility, and enabling personalized medicine escalate the usage of 3D printing in pharmaceutical industry.

About 1% of the drugs that are investigated make it through testing and gain approval. However, new technology is being pursued which accommodates increased precision in drug discovery. The advantage of 3D models is that it permits higher predictability of toxicity and effectiveness of a particular drug before it moves into the clinical trial phase, which in turn can reduce the attrition rate of new drugs and also speed up the new drug discovery process.

Will Innovation In Drug Delivery Drive Pharmaceutical Lactose Market?

The advent of new treatments will create interest in unique forms of drug delivery. The trend of new biological treatments is expected to continue through 2021. With the growing demand for higher health standards across the globe, there is increasing realization that the treatment of moderate conditions using conventional patient centric dosages presents a lucrative market. Specifically in the niche area of topicals, with the new guidelines and changes in the industry, the requirement for consistent production of complex semi solids can be anticipated to grow.

Country-wise Insights

Why Spain is leading the Europe Pharmaceutical Lactose Market?

Spain is leading the Europe pharmaceutical lactose market. Government support for hospitality services and development of treatment molecules and drugs in the country is an important factor driving pharmaceutical lactose market in Spain. Private insurance sector and medic aim in Spain is active with support to the patients with financial aids for several disease treatment this will push the pharmaceutical lactose market in Spain.

What is Driving Pharmaceutical Lactose Sales in Mexico?

Mexico is expected to continue at its leading position in forecast period with estimated market share of 23.2% by end of 2031. Latin America has a relatively smaller market share for healthcare and pharmaceutical and is slowly moving up the pharmaceutical sector growth ladder with a focus on innovation and adoption of advanced technologies across numerous industries.

Mexico is a rapidly growing hub for medical technology in Latin America. It has been attracting foreign investments in the Latin America. Increased penetration of leading pharmaceutical companies and adoption of new oral drug technologies in Mexico is anticipated to drive pharmaceutical lactose market in the country.

Will India’s Pharmaceutical Lactose Market Grow Exponentially?

The India market is expected to rise at the fastest CAGR in South Asia pharmaceutical lactose market. India is anticipated to grow with CAGR 6.9% in forecast period. Increasing research and development by regional as well as international players in India is projected to push the healthcare industry results in boost to pharmaceutical lactose market in the country.

South Asian countries showcase lower price range for drugs as compared to other regions. Increasing average dollar spending by India and ASEAN countries is escalating demand of the drugs resulting in growth of pharmaceutical lactose market across the region.

Why is Demand for Pharmaceutical Lactose Is Growing in China?

China’s pharmaceutical lactose market is anticipated to grow at a CAGR of little below 6% through 2031. China’s initiatives such as streamlining its state-owned enterprise (SOE) sector and introducing new amendments to current foreign investment laws will go a long way in ensuring enhanced economic stability in the country. The adoption of new technologies and increased penetration of the biological tools along with increasing research and development funds in China are expected to drive the market for pharmaceutical lactose during the forecast period.

Why is U.S. leading North America Pharmaceutical Lactose Market?

The U.S. is dominating the pharmaceutical lactose market in North America with market share of 60.6% in 2021. The increasing product adoption and presence of a well-established pharmaceutical industry are the major reasons for driving pharmaceutical lactose market in U.S. Continuous updates and technological advancements in the customized biologicals and advanced drugs are current trends in the regional market.

Category Wise

Why Α-Lactose Monohydrate Is The Top-Selling Product?

α-Lactose monohydrate is leading in terms of product type in the pharmaceutical lactose market with market share nearly 46% in 2021. The segment is expected to show significant growth in forecast period. In the pharmaceutical industry this type of lactose is used widely as an excipient in the production of solid dosage forms. In dry powder inhalers it is used as a carrier. The pharmaceutical products in which α-Lactose monohydrate used as a primary ingredient have higher shelf life as compared to other products in which rest of pharmaceutical lactose types used. 

Competitive Landscape for Pharmaceutical Lactose Market

The global pharmaceutical lactose market is witnessing a rise in competition as more and more market players belonging to the lactose industry are taking an interest in venturing in this B2B business model. The rising demand for pharmaceutical lactose is creating tremendous opportunities for market players manufacturing pharmaceutical lactose.

Due to rising competition in the pharmaceutical lactose market, key players are focusing on launching innovative new products of pharmaceutical lactose in the market to sustain the position in the pharmaceutical lactose market.

For instance-

  • In 2015, Meggle launched triple compound pharma grade lactose CombiLac®, specifically designed to ease oral solid dosage

The key players of pharmaceutical lactose are focusing on partnership and joint venture to expand their product portfolio as well as to strengthen their supply chain. The partnership help to increase the production capacity of pharmaceutical lactose as well as expand the geographical reach.

For instance-

  • In Aug 2020, Armor Pharma signed a partnership with Nordmann for expanding its product footprint. Nordmann, an international chemical distributor, is supplying the German market with pharmaceutical-grade lactose products from the French manufacturer Armor Pharma.

Some of the leading companies operating in the pharmaceutical lactose market are:

  • Ba'emek Advanced Technologies Ltd (Tnuva Group)
  • Hilmar Ingredients
  • Armor Pharma
  • Avantor, Inc.
  • Alpavit Käserei Champignon Hofmeister GmbH & Co. KG
  • Lactose (India) Limited
  • DFE Pharma
  • Hoogwegt Groep B.V.
  • Merck KgaA
  • Kerry plc
  • Milei GmbH
  • BASF SE
  • MEGGLE Excipients & Technology

*The list is not exhaustive, and only for representational purposes. Full competitive intelligence with SWOT analysis available in the report.

Scope of the Pharmaceutical Lactose Report

Attribute

Details

Forecast Period

2021-2031

Historical Data Available for

2016-2020

Pharmaceutical Lactose Market Analysis

USD Million for value and Metric Tons for Volume

Key Regions Covered

North America, Latin America, Europe, East Asia, South Asia, Oceania Middle East & Africa

Key Countries Covered

US, Canada, Brazil, Mexico, Chile, Peru, Argentina, Rest of Latin America, Germany, France, Italy, U.K., Spain, BENELUX, Nordic, Poland, Russia, Rest of Europe, China, Japan, South Korea, India, Malaysia, Singapore, Indonesia, Thailand, Rest of South Asia, Australia, New Zealand, GCC Countries, South Africa, Turkey, North Africa, Central Africa, Rest of MEA

Key Segments Covered

Product Type

Key Companies Profiled

  • Ba'emek Advanced Technologies Ltd (Tnuva Group)
  • Hilmar Ingredients
  • Armor Pharma
  • Avantor, Inc.
  • Alpavit Käserei Champignon Hofmeister GmbH & Co. KG
  • Lactose (India) Limited
  • DFE Pharma
  • Hoogwegt Groep B.V.
  • Merck KgaA
  • Kerry plc
  • Milei GmbH
  • BASF SE
  • MEGGLE Excipients & Technology

Pharmaceutical Lactose Report Coverage

Market Forecast, brand share analysis, competition intelligence, DROT analysis, Market Dynamics and Challenges, Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Key Questions Answered in the Pharmaceutical Lactose Report

  • Why is South Asia Considered Highly Lucrative For Pharmaceutical Lactose Sales?

    The South Asia market is expected to grow at above 6% CAGR in pharmaceutical lactose market during forecast period. Presence of several leading players and higher spending on drugs among consumers will enable growth in the market.

  • Why Α-Lactose Monohydrate Is The Preferred Pharmaceutical Lactose?

    α-Lactose monohydrate is anticipated to continue dominating the pharmaceutical lactose market in terms of product through 2031. The demand for excipients is rising rapidly across the globe, α-Lactose monohydrate is primary ingredient in excipients due to which its use is further expected to rise in near future.

  • Which are some of the leading companies offering pharmaceutical lactose market?

    Some of the key players operating in the pharmaceutical lactose market are Avantor, Inc., Ba'emek Advanced Technologies Ltd (Tnuva Group), Koninklijke FrieslandCampina N.V., Armor Pharma, Hilmar Ingredients Inc., Hoogwegt Groep B.V., Kerry Group plc, Lactose (India) Limited, Merck KGaA, BASF SE, Milei GmbH, and other playes.

  • What are the key strategies of leading companies in pharmaceutical lactose market?

    Key players in the pharmaceutical lactose market are focusing on launching high quality lactose products. Globally the number of new players entering in the market are growing due to which, completion is getting intense in the pharmaceutical lactose market.

  • Which technology pharmaceutical lactose manufactures are using?

    Cloud-based technologies are being incorporated in the development of pharmaceutical lactose. Continuous developments in cloud-based drug discovery platforms are anticipated to contribute significantly towards the growth of the global market for pharmaceutical lactose.

Enquiry before Buying

Is this research conducted by Future Market Insights?

Yes, the research has been conducted by expert analysts of Future Market Insights through a combination of primary research and secondary research. To know more about how the research was conducted, you can speak to research analyst

What research methodology is followed by FMI?

FMI follows a methodology that encompasses demand side assessment of the market, and triangulates the same through supply side analysis. This methodology is based on use of standard market structure, methods and definitions. Request detailed methodology

Who are the respondents for primary research?

FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. For a full list of primary respondents, please reach out to us.

What are the sources of secondary research?

FMI conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request

Is a sample of pharmaceutical lactose report available for evaluation?

Yes, you can request a sample for pharmaceutical lactose report and it will be sent to you through an email.

How can I buy pharmaceutical lactose report?

FMI provides a secure online payment system to buy report seamlessly. You can buy the pharmaceutical lactose report securely and safely.

Pharmaceutical Lactose Market by Category

Product Type

  • Β-Lactose
  • α-Lactose monohydrate
  • Amorphous lactose
  • Spray dried lactose

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Middle East and Africa (MEA)
  • Oceania

Need specific information?

In the news

How Businesses Can Utilize Market Research to Create Reactive, Recession-proof Strategies for Survival

by - Sudip Saha, Managing Director and Co-Founder of Future Market Insights

Our Clients

View Our Reports from Food and Beverage

View Reports

Recommendations

Pharmaceutical Lactose Market